Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Janne, Jonassen"'
Autor:
Ernst A. Lien, Kari Britt Hagen, Gunnar Mellgren, Martha Eimstad Haugstøyl, Jennifer Gjerde, Siri Lunde, Birgitta Haga Gripsrud, Ersilia Bifulco, Kirsten Lode, Turid Aas, Håvard Søiland, Emiel A. M. Janssen, Tone Hoel Lende, Ragna Lind, Janne Jonassen, Kristin Jonsdottir, Steinar Hustad, Jan Terje Kvaløy, Thomas Helland
Publikováno v:
Breast Cancer Research and Treatment. 177:185-195
Tamoxifen is an important targeted endocrine therapy in breast cancer. However, side effects and early discontinuation of tamoxifen remains a barrier for obtaining the improved outcome benefits of long-term tamoxifen treatment. Biomarkers predictive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32c0ce2a7c9afd875791d064fda56fe0
https://doi.org/10.1007/s10549-019-05294-w
https://doi.org/10.1007/s10549-019-05294-w
Autor:
Thomas, Helland, Kari Britt, Hagen, Martha Eimstad, Haugstøyl, Jan Terje, Kvaløy, Siri, Lunde, Kirsten, Lode, Ragna Anne, Lind, Birgitta Haga, Gripsrud, Kristin, Jonsdottir, Jennifer, Gjerde, Ersilia, Bifulco, Steinar, Hustad, Janne, Jonassen, Turid, Aas, Tone Hoel, Lende, Ernst Asbjørn, Lien, Emiel Adrianus Maria, Janssen, Håvard, Søiland, Gunnar, Mellgren
Publikováno v:
Breast cancer research and treatment. 177(1)
Tamoxifen is an important targeted endocrine therapy in breast cancer. However, side effects and early discontinuation of tamoxifen remains a barrier for obtaining the improved outcome benefits of long-term tamoxifen treatment. Biomarkers predictive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::586687122bcf75b7849e5af8507de05a
https://pubmed.ncbi.nlm.nih.gov/31144152
https://pubmed.ncbi.nlm.nih.gov/31144152